Alexandria Real Estate Equities (ARE)
Real Estate · Office REITs · NYSE
A real estate investment trust specializing in the development and management of high-quality life science and technology campus properties in key innovation clusters.
What Alexandria Real Estate Equities does
Alexandria Real Estate Equities is a real estate investment trust (REIT) that focuses on owning, operating, and developing collaborative life science, agtech, and technology campuses. The company provides high-quality office and laboratory space specifically designed to meet the unique requirements of the life science and technology industries. Its portfolio primarily consists of properties located in key innovation clusters across the United States.
Themes: life science real estate, innovation clusters, commercial real estate development
Fundamentals
- Price$53.49 as of 2026-08-21 close
- Market cap$9.3B as of 2026-08-21
- 1-year return-30.9% 2025-08-21 close $77.41 → 2026-08-21 close $53.49
- P/En/a negative earnings
- Net margin-36.6% as of 2026-08-24
- Gross margin+68.6% as of 2026-08-24
- ROE-6.5% as of 2026-08-24
- Debt / equity0.82 as of 2026-08-24
- Revenue growth (YoY)-13.0% as of 2026-08-24
- Beta1.19 as of 2026-08-24
- Last reported earnings2026-08-03 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +4.7%; 1-year non-decreasing per-share dividend streak (SEC XBRL).
How ARE compares in its sector
- net profit marginbottom 10% 161 covered Real Estate peers, as of 2026-08-24
- operating marginbottom 10% 161 covered Real Estate peers, as of 2026-08-24
- gross marginmiddle range 156 covered Real Estate peers, as of 2026-08-24
- return on equitybottom 25% 162 covered Real Estate peers, as of 2026-08-24
- indicated dividend yieldmiddle range 138 covered Real Estate peers, as of 2026-08-24
Position among covered Real Estate companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
ARE is not currently in any published Top 10 list. Its scores are below.
Long-term score
30.3 #946 of 987 scored · #83 of 84 in Real Estate
Valuation 99th (price to book 0.6) and financial health 44th (debt to equity 0.8); weakest is profitability (3rd, operating margin -51.9%, return on equity -6.5%).
Short-term score
47.6 #944 of 1,704 scored · #32 of 94 in Real Estate
Volume and participation 68th: trading volume is about normal versus its 30-day average; catalysts 65th: analysts have raised their average price target by 0.8% since the prior reading; weakest is setup 42nd: no fresh 20-day breakout up or down. Its score is docked 10 points for overextended (RSI above 75 or stochastic above 90).
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, ARE's dividend was covered by reported results (operating-cash-flow payout 64%). This describes past coverage, not a forecast.
- Earnings payoutnot assessable earnings were not positive that year
- Operating-cash-flow payout64% dividends / operating cash flow — capital spending was not reported, so this does not subtract it
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How Alexandria Real Estate Equities looks technically
Alexandria Real Estate Equities (ARE) is trading 6.6% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 8 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 18, below the 25 that marks a real trend), though buyers have been pushing harder than sellers lately — pressure, not a trend. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 60, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 2 trading days ago (its momentum flipped positive). It made a new 20-day low about 4 trading days ago. It is 39.4% below its highest point of the past year.
Trend
9
| Distance from the 200-day | it is trading 6.6% above its 200-day average, the long-term trend line — a longer-term uptrend | +6.6% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $50.61 | $50.61 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $50.20 | $50.20 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 23 calendar days ago — the swings before that are what the structure reading is measured on | 23 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes above 55.735. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible downward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 8 trading days ago — a "golden cross", a bullish long-term signal | 8 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 6.6% above | +6.6% |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 18, below the 25 that marks a real trend), though buyers have been pushing harder than sellers lately — pressure, not a trend | 18.1 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 60, neither overbought (above 70) nor oversold (below 30) | 60.3 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($45.78 to $54.01) — its "stochastic" reading is 94 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 93.7 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 2 trading days ago (its momentum flipped positive) | 2 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $88.24 | $88.24 |
|---|---|---|
| From the 52-week high | it is 39.4% below its 52-week high (its highest price of the past year) | -39.4% |
| Above the 52-week low | it is 35.7% above its 52-week low (its lowest price of the past year) | +35.7% |
| Below the 52-week high | it is 39.4% below its highest point of the past year | 39.4% |
| Since a 20-day breakout | it made a new 20-day low about 4 trading days ago | 4 sessions |
| Since a 55-day breakout | it made a new 55-day low about 4 trading days ago | 4 sessions |
| All-time high | its highest closing price on record is $224.95 (set on 2021-12-31) | $224.95 |
| Given back of the 52-week move | over the past year its closes ranged ($40.41 to $87.45), and it has recovered roughly a quarter of its fall from last year’s high — 28% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $69.48 to $70.99. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 27.8% |
| From the all-time high | it is 76.2% below its all-time high | -76.2% |
| Nearest price level | it is trading 2.5% below a resistance level at $54.80 — a price it turned at three times since 2025-11-28, most recently on 2026-06-15. Since 2024-08-21 it has 1 such level below the current price and 8 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +2.5% |
| All-time low | its lowest closing price on record is $30.33 (set on 2009-07-10) | $30.33 |
| Above the all-time low | it is 76.4% above its all-time low | +76.4% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are wider than usual versus its own recent 6-month history (wider than about 76% of it) | 76th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $2.07 between its high and its low — about 3.9% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $2.07 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $45.39 and $55.03 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $45.39 – $50.21 – $55.03 |
| Typical daily range (% of price) | its price moves about 3.9% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 3.9% |
| Stretch from the 200-day average | it is trading 1.6 daily ranges above its 200-day average price (6.6% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 1.6 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.71× |
|---|
Analyst
2
| Change in the average price target | analysts have raised their average price target by 0.8% since the prior reading | +0.8% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
2
| Since a doji | today it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | today |
|---|---|---|
| Since a bullish engulfing | 6 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 6 sessions ago |
Price gaps
3
| Gap at the open | it opened on 2026-08-21 0.7% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.7% |
|---|---|---|
| Open gap | it gapped 2.1% above the previous close 2 sessions ago and has not traded back through the level it left behind at 45.84 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +2.1% |
| Gap filled | a 2.1% gap down opened on 2026-08-04 has been "filled" 1 session ago — price traded back through the level the gap left behind, and it took 12 sessions to close | 1 session ago |
Price streaks
1
| Closing streak | it has closed higher 3 sessions in a row, a +16.69% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 3 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 3.4 percentage points (the stock gained 5.7% while the market gained 2.3%) | +3.4% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 8.7 percentage points (the stock gained 11.8% while the market gained 3.1%) | +8.7% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 11.4 percentage points (the stock lost 0.3% while the market gained 11.1%) | -11.4% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 51.4 percentage points (the stock lost 30.9% while the market gained 20.5%) | -51.4% |
Signal agreement
2
| Bullish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, MACD momentum is positive, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 4 of 9 |
|---|---|---|
| Bearish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bearish state: lagging the market over 6 months, near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 2 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 5.2% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 5.1% of the share price. | +5.2% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 6% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $50.30 — a volume-weighted average of daily closes over 159 sessions, not a true tick-by-tick VWAP. | +6.3% |
|---|---|---|
| Vs the average paid since it last reported | the price is 8% above the average price paid since it last reported on 2026-08-03 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $49.74 — a volume-weighted average of daily closes over 15 sessions, not a true tick-by-tick VWAP. | +7.5% |
Price levels it has turned at before
ARE last closed at $53.49 on 2026-08-21. Since 2024-08-21 it has turned at 1 price below its last close and 8 above; the nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $54.80 | Resistance | 2.5% above the last close | turned there three times · 2025-11-28 to 2026-06-15 |
| $55.97 | Resistance | 4.6% above the last close | turned there twice · 2026-06-26 to 2026-07-29 |
| $48.96 | Support | 8.5% below the last close | turned there four times · 2025-11-20 to 2026-06-17 |
| $71.24 | Resistance | 33.2% above the last close | turned there six times · 2025-04-09 to 2025-08-12 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes above $55.73.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $41.16 and $46.73 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close above $55.73.
This labelling was already in place when we began recording count changes on 2026-08-13, so how long it has stood is not something we can say yet.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Recent golden cross (50-day crossed above 200-day) · Tested and reclaimed 200-day support · Pulled back from the 12-month high · MACD just crossed bullish (12/26/9) · trendless / choppy (low ADX) | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingHold (2.94 mean, 1=Strong Buy…5=Strong Sell) — 14 analysts
- Mean price target$52.21 range $46.00 – $60.00; median $52.00
Analyst estimates, as of 2026-08-17. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for ARE
- Consensus EPS estimate$0.00 next reporting period, as of 2026-08-17
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Market demand and leasing activity in specific life science and technology innovation clusters","Sensitivity to interest rate fluctuations affecting financing and capitalization costs","Development and redevelopment project execution risk and capital intensity"]
What changed in the latest 10-Q
AI-assisted comparison of ARE's 10-Q filed 2026-04-27 against the prior one filed 2025-10-27.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-04-27) adds section on 'Impairment of real estate' describing $5.5 million in impairment charges recognized during three months ended March 31, 2026, primarily related to Canada portfolio amendment
- Newer filing (2026-04-27) adds detailed 'Other' subsection describing ARE-East River Science Park, LLC's option to incorporate land parcel adjacent to Alexandria Center for Life Science – New York City, with $180.6 million in pre-construction costs as of March 31, 2026
- Newer filing (2026-04-27) adds information about lawsuit filed August 6, 2024 against New York City Health + Hospitals Corporation and EDC, with amended complaint filed January 24, 2025, and court's partial motion to dismiss granted March 27, 2026
- Removed:
- Older filing (2025-10-27) includes detailed table of completed dispositions during nine months ended September 30, 2025 with property-by-property sales data; newer filing does not include comparable transaction table
- Older filing (2025-10-27) describes dispositions of Costa Verde by Alexandria, Pacific Technology Park, 5505 Morehouse Drive, Garcia Avenue/Bayshore Parkway, and Texas land parcel; newer filing contains no comparable disposition details
- Reworded:
- Newer filing (2026-04-27) states ASU will require 'enhanced disclosures related to certain expense categories included in line items on the statement of operations' versus older filing (2025-10-27) stating 'included in income statement line items'
- Newer filing (2026-04-27) states note adoption 'is expected to result in incremental disclosures within the notes to our consolidated financial statements' versus older filing (2025-10-27) stating 'within the footnotes to our consolidated financial statements'
- Newer filing (2026-04-27) describes held for sale assets with different characteristics: '19 operating properties aggregating 1.4 million RSF and land parcels aggregating 1.6 million SF' as of March 31, 2026 versus older filing (2025-10-27) showing '14 operating properties aggregating 1.8 million RSF and land parcels aggregating 939,756 SF' as of September 30, 2025
- Older filing (2025-10-27) states disposal 'does not represent a strategic shift that has (or will have) a major effect' versus newer filing (2026-04-27) states 'does not represent a strategic shift that has, or will have, a major effect' (punctuation change)
- Notes:
- The two filings cover different reporting periods (March 31, 2026 vs. September 30, 2025) with different balance sheet dates, making some differences reflect timing rather than policy changes
- Newer filing text appears truncated at end of lawsuit description ('and i'), limiting ability to assess complete changes in that section
- Real estate investment amounts differ substantially between filings due to different reporting dates and asset dispositions occurring between periods
Risk Factors
- Added:
- Table showing dispositions, impairments, and capitalization rates for 2024, 2025, and Q1 2026 (filed 2026-04-27)
- Discussion of 2026 disposition program with $2.90 billion midpoint guidance (filed 2026-04-27)
- Disclosure of $522.5 million in assets classified as held for sale as of March 31, 2026 (filed 2026-04-27)
- GAAP impairment evaluation criteria for held and used assets, held for sale assets, and probability-weighted approach (filed 2026-04-27)
- Statement that 78% of annual rental revenue is from Megacampus platform as of March 31, 2026 (filed 2026-04-27)
- Discussion of $1.68 billion targeted debt reduction in 2026 guidance (filed 2026-04-27)
- Details of February 2026 tender offers totaling $1.33 billion principal with 28% average discount and $380 million debt extinguishment (filed 2026-04-27)
- Disclosure of $750 million 5.25% senior notes due 2036 issuance (filed 2026-04-27)
- Disclosure of $200 million short-term commercial paper borrowings (filed 2026-04-27)
- Details of January 2026 repayment of $300 million 4.30% notes and April 2026 repayment of $350 million 3.80% notes (filed 2026-04-27)
- Table of unsecured senior notes issued showing 2024, 2025, and February 2026 issuances with interest rates (filed 2026-04-27)
- Table showing gross interest expense, capitalized interest, and net interest expense for 2024, 2025, Q1 2026, and 2026 guidance (filed 2026-04-27)
- Disclosure that capitalized interest expected to decrease to $245 million in 2026 due to project reevaluation and asset dispositions (filed 2026-04-27)
- Statement that interest expense expected to increase to $260 million in 2026 from $226.7 million in 2025 (filed 2026-04-27)
- Removed:
- Reference to risk factors within 'Part II – Other information' of quarterly report (filed 2025-10-27)
- Extensive discussion of potential impacts on revenues, operating performance, income from rentals, net operating income, occupancy, EPS, FFO metrics, Adjusted EBITDA, credit ratings (filed 2025-10-27)
- Discussion of equity offerings and asset sales as liquidity preservation measures (filed 2025-10-27)
- Discussion of potential dividend reduction (filed 2025-10-27)
- Mitigating factors section discussing Megacampus strategy and Class A/A+ assets (filed 2025-10-27)
- Reworded:
- Newer filing focuses on specific 2026 projections and recent transactions; older filing was more general discussion of potential adverse impacts (filed 2026-04-27 vs 2025-10-27)
- Notes:
- The older filing text appears truncated and incomplete, ending mid-sentence in the Megacampus strategy section
- The two filings appear to be different sections or editions of risk factor disclosures, potentially reflecting different reporting periods and updated guidance
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
1 open-market purchase and 1 open-market sale by insiders in the last 90 days.
- Last 30 days1 buy ($231400) · 0 sells — 1 buying insider
- Last 90 days1 buy ($231400) · 1 sell ($108000) — 1 buying, 1 selling insiders
- Last 180 days8 buys ($1M) · 2 sells ($133835) — 2 buying, 2 selling insiders
Activity heuristic: mixed (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-17. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about ARE's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Congressional trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 6 matched disclosures for ARE from U.S. House Clerk Periodic Transaction Report filings.
Congressional trading disclosures →Short interest (FINRA)
ARE had 6,878,589 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
ARE had 3.95% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 4.36 days to cover at the same settlement.
- Reported short interest (shares) 6,878,589
- Short interest (% of shares outstanding) 3.95%
- Prior settlement (shares) 7,824,611
- Reported change -12.09%
- Days to cover (reported) 4.36
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Boston Properties (BXP)
- Kilroy Realty (KRC)
- BioMed Realty (Blackstone)
- Healthpeak Properties
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare ARE vs…
Alexandria Real Estate Equities is found in…
Frequently asked questions
What does Alexandria Real Estate Equities (ARE) do?
Alexandria Real Estate Equities is a real estate investment trust (REIT) that focuses on owning, operating, and developing collaborative life science, agtech, and technology campuses. The company provides high-quality office and laboratory space specifically designed to meet the unique requirements of the life science and technology industries. Its portfolio primarily consists of properties located in key innovation clusters across the United States.
What sector is Alexandria Real Estate Equities (ARE) in?
Alexandria Real Estate Equities (ARE) is classified in the Real Estate sector. Its industry is Office REITs. It trades on NYSE.
Does ARE pay a dividend?
Yes — Alexandria Real Estate Equities (ARE) pays a dividend, with an indicated yield of about 4.72% and 1-year non-decreasing per-share dividend streak (SEC EDGAR XBRL) (market data, as of 2026-08-24). Informational only — not financial advice.
Who are Alexandria Real Estate Equities's (ARE) competitors?
Notable peers of Alexandria Real Estate Equities (ARE) include Boston Properties, Kilroy Realty, BioMed Realty (Blackstone) and Healthpeak Properties. This peer set is informational only — not financial advice.
Has there been recent Congressional stock trading in ARE?
Yes — we hold 6 matched STOCK Act disclosures for ARE from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is Alexandria Real Estate Equities (ARE) overbought or oversold right now?
Alexandria Real Estate Equities (ARE) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 60, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on ARE come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.